Improved Utilization Rate in Solid Organ Donors ≥80 Years: The 7-Year Tuscany Experience
- PMID: 40145941
- DOI: 10.1111/ctr.70142
Improved Utilization Rate in Solid Organ Donors ≥80 Years: The 7-Year Tuscany Experience
Erratum in
-
Correction to Clinical Transplantation Articles.Clin Transplant. 2025 Apr;39(4):e70158. doi: 10.1111/ctr.70158. Clin Transplant. 2025. PMID: 40232868 No abstract available.
Abstract
Introduction: The Tuscany Region has a quite high annual number of donors per million population (100 donors/pmp (annually)). Considering the increasing donor age and organ shortage, the donation and transplantation community needs to expand procurement and transplants from elderly donors. We assessed the utilization rate in donors aged ≥80 years during the study period (2018-2024) in Tuscany.
Methods: Our retrospective observational study comprised 809 donors aged ≥80 years. We compared Period 1 (from 2018 to 2020, before the COVID pandemic) to Period 2 (from 2021 to 2024, after the COVID pandemic).
Results: cDCD donors significantly increased in Period 2 (0.0001). The utilization rate increased from Period 1 to Period 2 (81.5% vs. 91.7%). In the study period (2018-2024), 377 liver transplants were performed. Overall graft and patient survival at 1, 3, and 5 years when an octogenarian graft was used was 89.4%, 85.0%, 81.8% and 92.5%, 88.7%, 85.5%, respectively. EAD (early allograft dysfunction) was observed in 2.9% of the cases, and IC (ischemic cholangiopathy) developed in 6.3% of the cases. Forty kidneys were transplanted into 22 patients, including 18 dual kidney transplants.
Conclusions: During the 7-year study period, donors aged ≥80 years represented a consistent subgroup, since they accounted for one-third of the overall donor population. The increase in utilization rate observed during the study period may be related to several factors, both in the procurement and the transplant phase.
Trial registration: Clinicaltrial.gov: #NCT04744389.
Keywords: brain death donors; donation after circulatory death; older donors; utilization rate.
© 2025 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
References
-
- CNT Data From Italian Health Ministry 2023, https://www.trapianti.salute.gov.it/trapianti/homeCnt.jsp.
-
- C. Lazzeri, M. Bonizzoli, D. Ghinolfi, et al., “Comorbidities and Age in Brain‐Dead Donors and Liver Transplantation: A 15‐Year Retrospective Investigation,” Experimental and Clinical Transplantation 18, no. 1 (2020): 60–64.
-
- W. S. Lee, S. Choi, J. Kang, D. Kim, and Y. Chun, “Changes in Clinical Features and Demographics in Donors After Brain Death Over the Past 20 Years: A Single‐Center Experience in the Republic of Korea,” Experimental and Clinical Transplantation 19, no. 6 (2021): 522–526.
-
- F. S. Beigee, F. Ghorbani, S. Shahryari, and M. Mojtabaee, “Demographic Differences Between Two 7‐Year Periods of Organ Donation in Iran: A Single‐Center Experience,” Experimental and Clinical Transplantation 17, no. Suppl 1 (2019): 242–245.
-
- J. C. Dayoub, F. Cortese, A. Anzic, T. Grum, and J. P. de Magalhães, “The Effects of Donor Age On Organ Transplants: A Review and Implications for Aging Research,” Experimental Gerontology 110 (2018): 230–232.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical
